STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

CoreWeave (CRWV) holder targets $3.5M founders share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) is the subject of a Form 144 notice indicating a proposed sale of common stock under Rule 144. CANIS MAJOR 2025 GRAT plans to sell 40,000 shares of CoreWeave common stock, identified as founders shares, through Morgan Stanley Smith Barney LLC Executive Financial Services.

The proposed sale has an approximate aggregate market value of $3,514,000.00, with CoreWeave reporting 458,871,690 common shares outstanding. The notice lists the intended sale date as August 24, 2026 and discloses that the securities were originally acquired on February 25, 2019 from the issuer.

Positive

  • None.

Negative

  • None.
Shares to be sold 40,000 shares Common stock proposed for sale by CANIS MAJOR 2025 GRAT under Rule 144
Aggregate market value of shares to be sold $3,514,000.00 Approximate market value for 40,000 CoreWeave common shares in the Form 144
Shares outstanding 458,871,690 shares CoreWeave common shares outstanding referenced in the Form 144
Intended sale date 08/24/2026 Planned date for the Rule 144 sale of 40,000 shares
Acquisition date of founders shares 02/25/2019 Date the 40,000 founders shares were acquired from the issuer
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Form 144 regulatory
"144: Filer Information 144: Issuer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Founders Shares financial
"Common | 02/25/2019 | Founders Shares | Issuer"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
10b5-1 Sales regulatory
"10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave."
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

FAQ

What does the Form 144 filing for CoreWeave, Inc. (CRWV) disclose?
It discloses that CANIS MAJOR 2025 GRAT has filed a notice to sell 40,000 shares of CoreWeave common stock under Rule 144, with an approximate aggregate market value of $3,514,000.00, using Morgan Stanley Smith Barney LLC Executive Financial Services as broker.

How many CoreWeave (CRWV) shares are proposed to be sold in this Form 144?
The filing states that 40,000 shares of CoreWeave, Inc. common stock are proposed to be sold for the account of CANIS MAJOR 2025 GRAT, identified as founders shares originally acquired on February 25, 2019 from the issuer.

What is the stated market value of the CoreWeave (CRWV) shares in the Form 144?
The Form 144 lists an approximate aggregate market value of $3,514,000.00 for the 40,000 shares of CoreWeave common stock to be sold for the account of CANIS MAJOR 2025 GRAT.

What is the approximate number of CoreWeave (CRWV) shares outstanding referenced in the Form 144?
The notice references 458,871,690 CoreWeave common shares outstanding in connection with the proposed Rule 144 sale of 40,000 shares by CANIS MAJOR 2025 GRAT; this figure describes total shares outstanding, not the amount being sold.

When were the CoreWeave (CRWV) shares to be sold originally acquired and from whom?
The filing states that the 40,000 CoreWeave common shares proposed for sale were acquired on February 25, 2019 as Founders Shares directly from the issuer, CoreWeave, Inc.

What is the intended sale date for the CoreWeave (CRWV) shares in this Form 144?
The Form 144 indicates an intended sale date of August 24, 2026 for the proposed sale of 40,000 CoreWeave common shares by CANIS MAJOR 2025 GRAT under Rule 144.

Which broker is listed for the CoreWeave (CRWV) Form 144 sale?
The broker listed for the proposed Rule 144 sale of 40,000 CoreWeave common shares is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR